New York City Blood Center Enterprises today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment approaches for Sickle...
The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc),for the treatment of...
